2019 Update on Salivary Gland Carcinoma: Anti-HER2 w/o or w/Chemo Docetaxel Is Highly Active for Salivary Duct, Levatinib As Palliative for Recurrent/Metastatic Adenoid Cystic Carcinoma
Comments 0
Login to view comments.
Click here to Login
